Cargando…
Decoy receptor 3 (DcR3) overexpression predicts the prognosis and pN2 in pancreatic head carcinoma
BACKGROUND: This study was carried out to examine decoy receptor 3 (DcR3) expression and investigate its clinical and prognostic significance in patients with pancreatic head carcinoma. METHODS: Tissue samples were obtained from 50 patients with pancreatic head carcinoma. DcR3 protein expression in...
Autores principales: | Zhou, Jian, Song, Shiduo, Li, Dechun, He, Songbing, Zhang, Bing, Wang, Zhenxin, Zhu, Xinguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946126/ https://www.ncbi.nlm.nih.gov/pubmed/24597666 http://dx.doi.org/10.1186/1477-7819-12-52 |
Ejemplares similares
-
‘Decoy’ and ‘non-decoy’ functions of DcR3 promote malignant potential in human malignant fibrous histiocytoma cells
por: TODA, MITSUNORI, et al.
Publicado: (2013) -
Decoy Receptor 3 (DcR3) as a Biomarker of Tumor Deterioration in Female Reproductive Cancers: A Meta-Analysis
por: Jiang, Mengtong, et al.
Publicado: (2016) -
Overexpression of DcR3 and Its Significance on Tumor Cell Differentiation and Proliferation in Glioma
por: Huang, Suning, et al.
Publicado: (2014) -
Research Progress of DcR3 in the Diagnosis and Treatment of Sepsis
por: Su, Jingqian, et al.
Publicado: (2023) -
DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin
por: Gao, Liqin, et al.
Publicado: (2017)